Table 1.
Glucocorticosteroid (GCS) Drug Interactions
| Drug | Drug-Drug Interaction | Cytochrome Association | Renal Impairment | Hepatic Impairment |
|---|---|---|---|---|
| Prednisone Budesonide M-prednisolone Prednisolone Dexamethasone |
Aminoglutethimide: decreases levels/therapeutic effects of GCS Amphotericin: increases hypokalemic effects of amphotericin B Antacid: may decrease the absorption of GCS Anticholinesterase: concurrent use can lead to profound weakness in myasthenia gravis patients Antidiabetic agents: may decrease hypoglycemic effects of diabetic medications Aprepitant: may increase serum levels/therapeutic effects of GCS Antifungal agents: may increase serum levels/therapeutic effects of GCS Barbiturates: may decrease levels/therapeutic effects of GCS Bile acid sequestrants: may reduce absorption of GCS Calcium channel blockers: may increase serum levels/therapeutic effects of GCS Cyclosporine: concurrent use may increase levels of cyclosporine Diuretics: hypokalemic effects may be increased Estrogens: may increase serum levels/therapeutic effects of GCS Fluoroquinolones: concurrent use can increase risk of tendinopathies (tendonitis, rupture), particularly in the elderly Isoniazid: decreased serum levels/therapeutic effects of GCS Macrolides: may increase serum levels/therapeutic effects of GCS Neuromuscular-blocking agents: concurrent use increases the risk of myopathy NSAIDs: concurrent use may lead to increased incidence of GI adverse effects Rifamycin derivatives: may decrease the levels/therapeutic effects of GCS Salicylates: concurrent use may increase GI adverse effects Thalidomide: concurrent use may increase the risk of toxic epidermal necrolysis and DVT Vaccine (dead organism): may decrease the effect of vaccines Vaccine (live organism): may increase the risk of infection. Usage of live vaccines is contraindicated in immunosuppressed patients Warfarin: concurrent use may increase anticoagulant effects Note: Corticosteroids interfere with calcium absorption. St. John's Wort may decrease corticosteroid levels. |
Substrate of CYP3A4 Induces CYP2C19, 3A4 |
Use with caution— fluid retention may occur | Use with caution— fluid retention may occur |
- DVT
deep vein thrombosis
- GI
gastrointestinal
- NSAIDS
nonsteroidal anti-inflammatory drugs.